During the past decade, Heart Care Research Foundation conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Heart Care Research Foundation" are "Bradycardia" (1 trials), "Cardiovascular Disease" (1 trials), "Sudden Cardiac Death" (1 trials) and "de Novo Coronary Lesions" (1 trials). Many other conditions were trialed in "Heart Care Research Foundation" in a lesser frequency.

Most popular intervention types in "Heart Care Research Foundation" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "AV Therapy Assessment-B301 investigational device" (1 trials) and "TAXUS™ Express2™ Paclitaxel-Eluting Coronary Stent System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Heart Care Research Foundation" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Heart Care Research Foundation". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Heart Care Research Foundation, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Heart Care Research Foundation, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".